Spire Wealth Management’s Precigen PGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PGEN
PCM
DC
TCM
BCM
IAM
Spire Wealth Management's PGEN Position: Q2 2026 in Review
Spire Wealth Management sold out of Precigen (PGEN) in Q2 2026, closing a stake of 800 shares — an estimated $3.1K sold.
Spire Wealth Management first reported a position in PGEN in Q1 2021 and held it in 21 quarters. The position peaked at $7K in Q1 2021. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.
- Spire Wealth Management reported no remaining Precigen position as of Q2 2026 after selling out during the quarter.
- Spire Wealth Management sold 800 Precigen shares in Q2 2026, an estimated $3.1K.
- Spire Wealth Management first reported a position in Precigen in Q1 2021 and held it in 21 quarters.
- Spire Wealth Management's Precigen position peaked at $7K in Q1 2021.
- 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.
Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.